Sheng-Yung Liu

This inventor holds 13 USPTO granted patents and 15 published patent applications, plus 7 CIPO patents and 9 EPO patents. Top assignee: Golden Biotechnology Corporation. Active years: 2010-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sheng-Yung Liu. Retrieved from https://idiyas.com/inventor/sheng-yung-liu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 15)

% Patents Active = 84.6

CIPO Patents = 7

EPO Patents = 9 (Patent Applications = 13)

Average Co-Inventor Count = 2.6

ph-index = 1

Forward Citations = 3(Granted Patents)

Location History:

Danshuei Township, Taipei County, TW (2010)
New Taipei, TW (2012 - 2023)

Company Filing History:

13 out of 20

Golden Biotechnology Corporation

patents

Years Active: 2010-2023

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11786485 - Methods and compositions for treating advanced stage non-small cell lung cancer (2023-10-17),

2. 11406605 - Therapeutic compositions for treating pancreatic cancer (2022-08-09),

3. 11364209 - Methods and compositions for treating atopic dermatitis (2022-06-21),

4. 10959963 - Method for the treatment of fatty liver disease (2021-03-30),

5. 10905656 - Methods and compositions for treating arteriosclerotic vascular diseases (2021-02-02),

6. 10858307 - Compositions and methods for treating liver cancer (2020-12-08),

7. 10406120 - Methods and compositions for treating kidney disorders (2019-09-10),

8. 9861592 - Methods and compositions for treating neurodegenerative diseases (2018-01-09),

9. 9403747 - Methods and compositions for treating leukemia (2016-08-02),

10. 9365481 - Cyclohexenone compositions and process for making thereof (2016-06-14),

11. 8648117 - Methods and compositions for treating cancer metastasis (2014-02-11),

12. 8309611 - Methods and compositions for treating lung cancer (2012-11-13),

13. 7749546 - Composition for effectively suppressing the growth of prostate cancer cell, suppressing the prostatic hyperplasia and its preparation method (2010-07-06),

Title: Innovations by Sheng-Yung Liu in Cancer Treatment

Introduction

Sheng-Yung Liu is a prominent inventor based in New Taipei, Taiwan. He has made significant contributions to the field of cancer treatment, holding a total of 13 patents. His work focuses on developing innovative methods and compositions aimed at treating various types of cancer.

Latest Patents

Among his latest patents are methods and compositions for treating advanced stage non-small cell lung cancer. This invention provides novel approaches using cyclohexenone compounds to combat this aggressive form of cancer. Additionally, he has developed therapeutic compositions for treating pancreatic cancer, which include a cyclohexenone compound combined with one or more anti-cancer agents.

Career Highlights

Sheng-Yung Liu is associated with Golden Biotechnology Corporation, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on cancer therapies, showcasing his dedication to improving patient outcomes.

Collaborations

Some of his notable coworkers include Chih-Ming Chen and Wu-Che Wen, who contribute to the collaborative efforts in their research initiatives.

Conclusion

Sheng-Yung Liu's innovative work in cancer treatment exemplifies the importance of research and development in the medical field. His contributions are paving the way for new therapeutic options for patients battling cancer.

Profile summary based on public USPTO records.